| Insider-Aktien | 5.253.968 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Aeglea BioTherapeutics Inc Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in AGLE / Aeglea BioTherapeutics Inc getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in AGLE / Aeglea BioTherapeutics Inc. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-03 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 75,0000 | -8.333 | -625 | 0 | ||||
| 2026-06-03 | 2026-06-03 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 27,4600 | 8.333 | 229 | 8.333 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 71,3800 | -3.294 | -235 | 597.540 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 70,5000 | -8.149 | -575 | 600.834 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 69,4000 | -3.557 | -247 | 608.983 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 72,0600 | -3.100 | -223 | 97.994 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 70,7700 | -2.599 | -184 | 101.094 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 69,7500 | -1.801 | -126 | 103.693 | ||||
| 2026-06-03 | 2026-06-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 14,5000 | 7.500 | 109 | 105.494 | ||||
| 2026-05-08 | 2026-05-08 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 75,3500 | -19.269 | -1.452 | 88.606 | ||||
| 2026-05-08 | 2026-05-08 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 74,7600 | -24.814 | -1.855 | 107.875 | ||||
| 2026-05-08 | 2026-05-08 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 73,7200 | -33.513 | -2.471 | 132.689 | ||||
| 2026-05-08 | 2026-05-08 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 72,5700 | -2.404 | -174 | 166.202 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 71,3700 | -12.500 | -892 | 97.994 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 14,5000 | 12.500 | 181 | 110.494 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 74,9600 | -300 | -22 | 612.540 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 74,2300 | -1.700 | -126 | 612.840 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 73,1400 | -3.100 | -227 | 614.540 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 71,7600 | -1.000 | -72 | 617.640 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 70,7700 | -3.600 | -255 | 618.640 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 69,5400 | -5.300 | -369 | 622.240 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 75,3700 | -400 | -30 | 0 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 74,6000 | -5.059 | -377 | 400 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 73,7400 | -10.358 | -764 | 5.459 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 72,9400 | -12.777 | -932 | 15.817 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 71,5600 | -8.777 | -628 | 28.594 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 70,6100 | -19.656 | -1.388 | 37.371 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 69,5300 | -21.306 | -1.481 | 57.027 | ||||
| 2026-05-01 | 2026-05-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 27,4600 | 78.333 | 2.151 | 78.333 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 49,9200 | -2.656 | -133 | 627.540 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 49,2000 | -12.344 | -607 | 630.196 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 50,0000 | -7.958 | -398 | 0 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Sloan Sheldon | SYRE | Common Stock | D | 21,6600 | 7.958 | 172 | 7.958 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 49,9800 | -1.300 | -65 | 97.994 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 49,2100 | -6.200 | -305 | 99.294 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Burrows Scott L | SYRE | Common Stock | D | 14,5000 | 7.500 | 109 | 105.494 | ||||
| 2026-03-03 | 2026-03-03 | 4 | Burrows Scott L | SYRE | Common Stock | D | 41,6600 | -200 | -8 | 97.994 | ||||
| 2026-03-03 | 2026-03-03 | 4 | Burrows Scott L | SYRE | Common Stock | D | 40,5600 | -2.300 | -93 | 98.194 | ||||
| 2026-03-03 | 2026-03-03 | 4 | Burrows Scott L | SYRE | Common Stock | D | 14,5000 | 2.500 | 36 | 100.494 | ||||
| 2026-03-03 | 2026-03-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 42,4900 | -9.100 | -387 | 642.540 | ||||
| 2026-03-03 | 2026-03-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 41,7300 | -5.900 | -246 | 651.640 | ||||
| 2026-02-04 | 2026-02-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 32,8700 | -14.043 | -462 | 657.540 | ||||
| 2026-02-04 | 2026-02-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 31,8200 | -957 | -30 | 671.583 | ||||
| 2026-01-23 | 2026-01-21 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 63.227 | 168.606 | ||||||
| 2026-01-06 | 2026-01-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 32,3900 | -100 | -3 | 671.907 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 31,7900 | -2.191 | -70 | 672.007 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Turtle Cameron | SYRE | Common Stock | D | 30,4700 | -12.709 | -387 | 674.198 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 29,8300 | -4.005 | -119 | 686.907 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Turtle Cameron | SYRE | Common Stock | D | 28,7300 | -10.995 | -316 | 690.912 | ||||
| 2025-11-05 | 2025-11-03 | 4 | Turtle Cameron | SYRE | Common Stock | D | 23,6600 | -16.845 | -399 | 701.907 | ||||
| 2025-11-05 | 2025-11-03 | 4 | Turtle Cameron | SYRE | Common Stock | D | 23,1300 | -28.155 | -651 | 718.752 | ||||
| 2025-09-03 | 2025-09-02 | 4 | Burrows Scott L | SYRE | Common Stock | D | 16,2600 | -18.428 | -300 | 97.994 | ||||
| 2025-01-14 | 2025-01-10 | 4 | HENDERSON MICHAEL THOMAS | SYRE | Common Stock | D | 105.379 | 105.379 | ||||||
| 2024-11-08 | 2024-11-06 | 4 | Albers Jeffrey W. By Sessions LLC | SYRE | Common Stock | I | 36,7631 | -6.700 | -246 | 27.360 | ||||
| 2024-10-28 | 2024-10-25 | 4 | Albers Jeffrey W. By Sessions LLC | SYRE | Common Stock | I | 36,4300 | -300 | -11 | 34.060 | ||||
| 2024-09-05 | 2024-09-03 | 4 | Burrows Scott L | SYRE | Common Stock | D | 28,1730 | -18.531 | -522 | 116.422 | ||||
| 2024-04-25 | 2024-04-25 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. | SYRE | Common Stock | I | 3.639.680 | 4.018.101 | ||||||
| 2024-02-20 | 2024-02-15 | 4 | Turtle Cameron | SYRE | Common Stock | D | 9,8200 | 400 | 4 | 746.907 | ||||
| 2023-12-29 | 2023-12-29 | 4 | Fairmount Funds Management LLC By Peter Harwin | SYRE | Common Stock | I | 406.038 | 406.038 | ||||||
| 2023-12-29 | 2023-12-29 | 4 | Fairmount Funds Management LLC By Tomas Kiselak | SYRE | Common Stock | I | 406.038 | 406.038 | ||||||
| 2023-12-29 | 2023-12-29 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Co-Invest L.P. | SYRE | Common Stock | I | -3.435.480 | 0 | ||||||
| 2023-12-22 | 2023-12-22 | 4 | Burrows Scott L | SYRE | Common Stock | D | 134.953 | 134.953 | ||||||
| 2023-12-08 | 2023-11-24 | 4/A | Albers Jeffrey W. By Sessions LLC | SYRE | Common Stock | I | 34.360 | 34.360 | ||||||
| 2023-11-28 | 2023-11-24 | 4 | Fairmount Funds Management LLC By Fairmount Healthcare Co-Invest L.P. | AGLE | Common Stock | I | 3.435.480 | 3.435.480 | ||||||
| 2023-11-27 | 2023-11-24 | 4 | Turtle Cameron | AGLE | Common Stock | D | 723.440 | 746.507 | ||||||
| 2023-06-30 | 3 | Turtle Cameron | AGLE | Common Stock | D | 576.699 | ||||||||
| 2023-06-30 | 3 | Fairmount Funds Management LLC By Fairmount Healthcare Fund II LP | AGLE | Common Stock | I | 9.184.458 | ||||||||
| 2023-06-30 | 3 | Fairmount Funds Management LLC By Fairmount Healthcare Fund LP( | AGLE | Common Stock | I | 276.082 | ||||||||
| 2023-01-27 | 3 | Neuman Linda L | AGLE | Common Stock | D | 4.000 | ||||||||
| 2022-08-25 | 3 | Kastenmayer James Paul | AGLE | Common Stock | D | 4.000 | ||||||||
| 2022-08-25 | 2022-08-25 | 4 | Souza Marcio | AGLE | Common Stock | D | 0,5608 | 90.000 | 50 | 90.000 | ||||
| 2022-06-10 | 2022-06-08 | 4 | Hanley Jr. Michael Conick | AGLE | Common Stock | D | 0,7100 | 28.200 | 20 | 36.200 | ||||
| 2022-03-18 | 2022-03-16 | 4 | Quinn Anthony | AGLE | Common Stock | D | 2,3440 | 80.079 | 188 | 550.540 | ||||
| 2022-03-15 | 2022-03-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 1,8611 | 42.417 | 79 | 473.461 | ||||
| 2022-03-15 | 2022-03-14 | 4 | Quinn Anthony | AGLE | Common Stock | D | 1,9300 | 67.472 | 130 | 431.044 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Quinn Anthony | AGLE | Common Stock | D | 2,0640 | 34.777 | 72 | 363.572 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Alspaugh Jonathan | AGLE | Common Stock | D | 2,0800 | 75.000 | 156 | 165.372 | ||||
| 2022-02-22 | 2022-02-17 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 3,17 | 350.000 | 350.000 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Weber Steven | AGLE | Employee Stock Option (right to buy) | D | 3,17 | 30.000 | 30.000 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Sloan Leslie | AGLE | Employee Stock Option (right to buy) | D | 3,17 | 180.000 | 180.000 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Hanley Jr. Michael Conick | AGLE | Employee Stock Option (right to buy) | D | 3,17 | 160.000 | 160.000 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Alspaugh Jonathan | AGLE | Employee Stock Option (right to buy) | D | 3,17 | 170.000 | 170.000 | |||||
| 2022-02-14 | 2021-10-20 | 5 | Quinn Anthony | AGLE | Common Stock | I | 10.000 | 208.845 | ||||||
| 2022-02-14 | 2021-10-20 | 5 | Quinn Anthony | AGLE | Common Stock | D | -10.000 | 328.795 | ||||||
| 2022-02-14 | 2021-10-18 | 5 | Quinn Anthony | AGLE | Common Stock | I | 23.809 | 208.845 | ||||||
| 2022-02-14 | 2021-10-18 | 5 | Quinn Anthony | AGLE | Common Stock | D | -23.809 | 328.795 | ||||||
| 2022-02-14 | 2021-10-14 | 5 | Quinn Anthony | AGLE | Common Stock | I | 175.036 | 208.845 | ||||||
| 2022-02-14 | 2021-10-14 | 5 | Quinn Anthony | AGLE | Common Stock | D | -175.036 | 328.795 | ||||||
| 2022-02-14 | 2018-12-28 | 5 | Quinn Anthony | AGLE | Common Stock | I | 57.450 | 57.450 | ||||||
| 2022-02-14 | 2018-12-28 | 5 | Quinn Anthony | AGLE | Common Stock | D | -57.450 | 328.795 | ||||||
| 2021-12-13 | 2021-12-13 | 4 | Shanafelt Armen | AGLE | Common Stock | D | 3,6500 | 14.685 | 54 | 150.000 | ||||
| 2021-12-13 | 2021-12-10 | 4 | Shanafelt Armen | AGLE | Common Stock | D | 3,6500 | 13.516 | 49 | 135.315 | ||||
| 2021-12-13 | 2021-12-09 | 4 | Shanafelt Armen | AGLE | Common Stock | D | 3,6680 | 121.799 | 447 | 121.799 | ||||
| 2021-12-13 | 2021-12-10 | 4 | Quinn Anthony | AGLE | Common Stock | D | 3,7500 | 10.526 | 39 | 328.795 | ||||
| 2021-12-13 | 2021-12-09 | 4 | Quinn Anthony | AGLE | Common Stock | D | 3,7000 | 43.108 | 159 | 318.269 | ||||
| 2021-12-13 | 2021-12-09 | 4 | Alspaugh Jonathan | AGLE | Common Stock | D | 3,7200 | 50.000 | 186 | 90.372 | ||||
| 2021-11-16 | 2021-11-12 | 4 | Smith Hunter C | AGLE | Director Stock Option (right to buy) | D | 7,04 | 60.000 | 60.000 | |||||
| 2021-08-18 | 2021-08-18 | 4 | Alspaugh Jonathan | AGLE | Common Stock | D | 6,7222 | 7.200 | 48 | 40.372 | ||||
| 2021-08-18 | 2021-08-17 | 4 | Alspaugh Jonathan | AGLE | Common Stock | D | 6,4973 | 23.392 | 152 | 33.172 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Alspaugh Jonathan | AGLE | Common Stock | D | 6,3676 | 9.780 | 62 | 9.780 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Alspaugh Jonathan | AGLE | Employee Stock Option (right to buy) | D | 7,03 | 160.000 | 160.000 | |||||
| 2021-06-22 | 2021-06-18 | 4 | Souza Marcio | AGLE | Director Stock Option (right to buy) | D | 6,44 | 60.000 | 60.000 | |||||
| 2021-06-10 | 2021-06-08 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AGLE | Non-Qualified Stock Option (right to buy) | I | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Magovcevic Ivana | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | LAWLIS V BRYAN | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Lawton Alison Frances | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 6,80 | 40.000 | 40.000 | |||||
| 2021-02-25 | 3 | BAKER JULIAN See Footnotes | AGLE | Common Stock | I | 3.094.590 | ||||||||
| 2021-02-25 | 3 | BAKER JULIAN See Footnotes | AGLE | Common Stock | I | 315.516 | ||||||||
| 2021-02-25 | 2021-02-23 | 4 | BAKER BROS. ADVISORS LP See Footnotes | AGLE | Non-Qualified Stock Option (right to buy) | I | 7,11 | 47.200 | 47.200 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Weber Steven | AGLE | Employee Stock Option (right to buy) | D | 7,35 | 50.000 | 50.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Sloan Leslie | AGLE | Employee Stock Option (right to buy) | D | 7,35 | 160.000 | 160.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 7,35 | 330.000 | 330.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Hanley Jr. Michael Conick | AGLE | Employee Stock Option (right to buy) | D | 7,35 | 135.000 | 135.000 | |||||
| 2021-02-08 | 3 | Weber Steven | AGLE | Common Stock | D | 17.652 | ||||||||
| 2020-12-17 | 2020-12-15 | 4 | Lawton Alison Frances | AGLE | Director Stock Option (right to buy) | D | 9,09 | 47.200 | 47.200 | |||||
| 2020-06-10 | 2020-06-08 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-06-10 | 2020-06-08 | 4 | Bruhn Suzanne Louise | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-06-10 | 2020-06-08 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-06-10 | 2020-06-08 | 4 | LAWLIS V BRYAN | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-06-10 | 2020-06-08 | 4 | Magovcevic Ivana | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-06-10 | 2020-06-08 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 8,89 | 28.100 | 28.100 | |||||
| 2020-05-04 | 2020-04-30 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,7500 | 165.000 | 784 | 538.469 | ||||
| 2020-02-19 | 2020-02-14 | 4 | Rao Madduri Ravin | AGLE | Employee Stock Option (right to buy) | D | 8,15 | 25.000 | 25.000 | |||||
| 2020-02-19 | 2020-02-14 | 4 | Sloan Leslie | AGLE | Employee Stock Option (right to buy) | D | 8,15 | 100.000 | 100.000 | |||||
| 2020-02-19 | 2020-02-14 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 8,15 | 126.000 | 126.000 | |||||
| 2020-02-19 | 2020-02-14 | 4 | Hanley Jr. Michael Conick | AGLE | Employee Stock Option (right to buy) | D | 8,15 | 25.000 | 25.000 | |||||
| 2020-02-19 | 2020-02-14 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 8,15 | 301.000 | 301.000 | |||||
| 2019-11-04 | 2019-11-01 | 4 | Rao Madduri Ravin | AGLE | Employee Stock Option (right to buy) | D | 8,24 | 130.000 | 130.000 | |||||
| 2019-10-23 | 2019-10-21 | 4 | Hanley Jr. Michael Conick | AGLE | Employee Stock Option (right to buy) | D | 7,79 | 130.000 | 130.000 | |||||
| 2019-10-07 | 2019-10-04 | 4 | Quinn Anthony | AGLE | Stock Option (right to buy) | D | 6,31 | -17.603 | 119.914 | |||||
| 2019-10-07 | 2019-10-04 | 4 | Quinn Anthony | AGLE | Stock Option (right to buy) | D | 5,46 | -662 | 0 | |||||
| 2019-10-07 | 2019-10-04 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,3100 | 17.603 | 111 | 371.908 | ||||
| 2019-10-07 | 2019-10-04 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,4600 | 662 | 4 | 354.305 | ||||
| 2019-06-14 | 2019-06-14 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,2311 | 5.282 | 33 | 353.643 | ||||
| 2019-06-14 | 2019-06-13 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,1666 | 14.406 | 89 | 348.361 | ||||
| 2019-06-14 | 2019-06-12 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,1148 | 12.217 | 75 | 333.955 | ||||
| 2019-06-07 | 2019-06-07 | 4 | Bruhn Suzanne Louise | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-06-07 | 2019-06-07 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-06-07 | 2019-06-07 | 4 | Magovcevic Ivana | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-06-07 | 2019-06-07 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-06-07 | 2019-06-07 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-06-07 | 2019-06-07 | 4 | LAWLIS V BRYAN | AGLE | Director Stock Option (right to buy) | D | 6,33 | 12.400 | 12.400 | |||||
| 2019-05-22 | 2019-05-22 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,8596 | 3.809 | 26 | 321.738 | ||||
| 2019-05-22 | 2019-05-21 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,8857 | 13.794 | 95 | 317.929 | ||||
| 2019-05-22 | 2019-05-20 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,5550 | 8.989 | 59 | 304.135 | ||||
| 2019-05-17 | 2019-05-17 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,6477 | 6.218 | 41 | 295.146 | ||||
| 2019-05-17 | 2019-05-16 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,8280 | 5.520 | 38 | 288.928 | ||||
| 2019-05-17 | 2019-05-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,7566 | 6.256 | 42 | 283.408 | ||||
| 2019-05-17 | 2019-02-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 7,0980 | 719 | 5 | 277.152 | ||||
| 2019-03-08 | 2019-03-06 | 4 | Sloan Leslie | AGLE | Employee Stock Option (right to buy) | D | 8,06 | 36.000 | 36.000 | |||||
| 2019-03-01 | 2019-02-28 | 4 | Quinn Anthony | AGLE | Stock Option (right to buy) | D | 8,36 | 280.000 | 280.000 | |||||
| 2019-03-01 | 2019-02-28 | 4 | Schuchart Aaron | AGLE | Employee Stock Option (right to buy) | D | 8,36 | 60.000 | 60.000 | |||||
| 2019-03-01 | 2019-02-28 | 4 | Wooldridge James | AGLE | Employee Stock Option (right to buy) | D | 8,36 | 50.200 | 50.200 | |||||
| 2019-03-01 | 2019-02-28 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 8,36 | 87.600 | 87.600 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Quinn Anthony | AGLE | Stock Option (right to buy) | D | 6,31 | -7.433 | 137.517 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Quinn Anthony | AGLE | Stock Option (right to buy) | D | 5,46 | -1.323 | 662 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,3100 | 7.433 | 47 | 276.433 | ||||
| 2019-02-08 | 2019-02-06 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,4600 | 1.323 | 7 | 269.000 | ||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 6,31 | -18.584 | 144.950 | |||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 5,46 | -3.306 | 1.985 | |||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 4,11 | -150.000 | 0 | |||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,3100 | 18.584 | 117 | 267.677 | ||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,4600 | 3.306 | 18 | 249.093 | ||||
| 2018-12-10 | 2018-12-07 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,1100 | 150.000 | 616 | 245.787 | ||||
| 2018-12-10 | 2018-08-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 9,1300 | 994 | 9 | 95.787 | ||||
| 2018-12-10 | 2018-02-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,0200 | 2.000 | 12 | 94.793 | ||||
| 2018-09-28 | 2018-09-27 | 4 | Schuchart Aaron | AGLE | Common Stock | D | 9,5000 | -5.900 | -56 | 2.500 | ||||
| 2018-09-28 | 2018-09-27 | 4 | Schuchart Aaron | AGLE | Common Stock | D | 9,5500 | -100 | -1 | 8.400 | ||||
| 2018-08-21 | 2018-08-17 | 4 | Schuchart Aaron | AGLE | Employee Stock Option (right to buy) | D | 3,50 | -8.500 | 91.500 | |||||
| 2018-08-21 | 2018-08-17 | 4 | Schuchart Aaron | AGLE | Common Stock | D | 3,5000 | 8.500 | 30 | 8.500 | ||||
| 2018-08-15 | 2018-08-13 | 4 | GEORGIOU GEORGE | AGLE | Director Stock Option (right to buy) | D | 4,73 | -20.000 | 10.000 | |||||
| 2018-08-15 | 2018-08-13 | 4 | GEORGIOU GEORGE | AGLE | Director Stock Option (right to buy) | D | 7,28 | -17.333 | 6.667 | |||||
| 2018-08-15 | 2018-08-13 | 4 | GEORGIOU GEORGE | AGLE | Common Stock | D | 4,7300 | 20.000 | 95 | 175.861 | ||||
| 2018-08-15 | 2018-08-13 | 4 | GEORGIOU GEORGE | AGLE | Common Stock | D | 7,2800 | 17.333 | 126 | 155.861 | ||||
| 2018-07-20 | 2018-07-18 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 9,36 | 50.000 | 50.000 | |||||
| 2018-07-20 | 2018-07-18 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 9,36 | 75.000 | 75.000 | |||||
| 2018-07-20 | 2018-07-18 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 9,36 | 75.000 | 75.000 | |||||
| 2018-07-20 | 2018-07-18 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 9,36 | 300.000 | 300.000 | |||||
| 2018-07-17 | 2018-07-13 | 4 | LAWLIS V BRYAN | AGLE | Director Stock Option (right to buy) | D | 8,78 | 36.800 | 36.800 | |||||
| 2018-07-16 | 2018-07-12 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 6,31 | -14.866 | 163.534 | |||||
| 2018-07-16 | 2018-07-12 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 7,04 | -24.000 | 0 | |||||
| 2018-07-16 | 2018-07-12 | 4 | Quinn Anthony | AGLE | Common Stock | D | 6,3100 | 14.866 | 94 | 92.793 | ||||
| 2018-07-16 | 2018-07-12 | 4 | Quinn Anthony | AGLE | Common Stock | D | 7,0400 | 24.000 | 169 | 77.927 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 5,46 | -3.307 | 5.291 | |||||
| 2018-07-13 | 2018-07-11 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,4600 | 3.307 | 18 | 53.927 | ||||
| 2018-06-08 | 2018-06-07 | 4 | Bruhn Suzanne Louise | AGLE | Director Stock Option (right to buy) | D | 10,28 | 18.400 | 18.400 | |||||
| 2018-06-08 | 2018-06-07 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 10,28 | 18.400 | 18.400 | |||||
| 2018-06-08 | 2018-06-07 | 4 | GEORGIOU GEORGE | AGLE | Director Stock Option (right to buy) | D | 10,28 | 18.400 | 18.400 | |||||
| 2018-06-08 | 2018-06-07 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 10,28 | 18.400 | 18.400 | |||||
| 2018-06-08 | 2018-06-07 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 10,28 | 18.400 | 18.400 | |||||
| 2018-05-14 | 2018-05-11 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,0600 | -19.550 | -197 | 2.175.314 | ||||
| 2018-05-11 | 2018-05-10 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,1300 | -22.725 | -230 | 2.194.864 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,1100 | -51.230 | -518 | 2.217.589 | ||||
| 2018-05-09 | 2018-05-08 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,0300 | -26.557 | -266 | 2.268.819 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,1100 | -15.548 | -157 | 2.295.376 | ||||
| 2018-03-26 | 2018-03-22 | 4 | Magovcevic Ivana | AGLE | Director Stock Option (right to buy) | D | 10,50 | 36.800 | 36.800 | |||||
| 2018-02-22 | 2018-02-20 | 4 | Schuchart Aaron | AGLE | Employee Stock Option (right to buy) | D | 6,31 | 20.000 | 20.000 | |||||
| 2018-02-22 | 2018-02-20 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 6,31 | 178.400 | 178.400 | |||||
| 2018-02-22 | 2018-02-20 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 6,31 | 92.100 | 92.100 | |||||
| 2018-02-22 | 2018-02-20 | 4 | Wooldridge James | AGLE | Employee Stock Option (right to buy) | D | 6,31 | 45.000 | 45.000 | |||||
| 2018-02-20 | 2018-02-15 | 4 | Quinn Anthony | AGLE | Director Stock Option (right to buy) | D | 5,46 | -15.211 | 8.598 | |||||
| 2018-02-20 | 2018-02-15 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,4600 | 15.211 | 83 | 50.620 | ||||
| 2017-12-08 | 2017-12-08 | 4 | Quinn Anthony | AGLE | Common Stock | D | 5,0650 | 600 | 3 | 35.409 | ||||
| 2017-12-08 | 2017-12-07 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,9882 | 2.800 | 14 | 34.809 | ||||
| 2017-12-08 | 2017-12-06 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,9248 | 4.888 | 24 | 32.009 | ||||
| 2017-12-05 | 2017-12-01 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 4,73 | 30.000 | 30.000 | |||||
| 2017-12-05 | 2017-12-01 | 4 | GEORGIOU GEORGE | AGLE | Director Stock Option (right to buy) | D | 4,73 | 30.000 | 30.000 | |||||
| 2017-12-05 | 2017-12-01 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 4,73 | 30.000 | 30.000 | |||||
| 2017-12-05 | 2017-12-05 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,9310 | 5.065 | 25 | 27.121 | ||||
| 2017-12-05 | 2017-12-04 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,9804 | 7.956 | 40 | 22.056 | ||||
| 2017-12-05 | 2017-12-01 | 4 | Quinn Anthony | AGLE | Common Stock | D | 4,5312 | 4.100 | 19 | 14.100 | ||||
| 2017-12-05 | 2017-12-01 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 4,73 | 30.000 | 30.000 | |||||
| 2017-12-05 | 2017-12-05 | 4 | York Charles N II | AGLE | Common Stock | D | 4,7554 | 10.241 | 49 | 34.787 | ||||
| 2017-12-05 | 2017-12-04 | 4 | York Charles N II | AGLE | Common Stock | D | 4,9699 | 3.259 | 16 | 24.546 | ||||
| 2017-12-05 | 2017-12-01 | 4 | York Charles N II | AGLE | Common Stock | D | 4,5931 | 6.500 | 30 | 21.287 | ||||
| 2017-12-05 | 2017-08-15 | 4 | York Charles N II | AGLE | Common Stock | D | 2,5160 | 1.959 | 5 | 14.787 | ||||
| 2017-12-05 | 2017-02-15 | 4 | York Charles N II | AGLE | Common Stock | D | 4,2840 | 2.000 | 9 | 12.828 | ||||
| 2017-12-05 | 2016-08-15 | 4 | York Charles N II | AGLE | Common Stock | D | 3,9870 | 2.000 | 8 | 10.828 | ||||
| 2017-09-01 | 2017-08-31 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 4,11 | 150.000 | 150.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | Rowlinson Scott W | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 25.000 | 25.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | Schuchart Aaron | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 10.000 | 10.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | TYLER JOSEPH E | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 25.000 | 25.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | Wooldridge James | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 10.000 | 10.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | Wooldridge James | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 165.000 | 165.000 | |||||
| 2017-08-24 | 2017-08-22 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 3,10 | 58.500 | 58.500 | |||||
| 2017-06-20 | 2017-06-16 | 4 | Schuchart Aaron | AGLE | Employee Stock Option (right to buy) | D | 3,50 | 100.000 | 100.000 | |||||
| 2017-04-25 | 2017-04-21 | 4 | Quinn Anthony | AGLE | Employee Stock Option (right to buy) | D | 7,04 | 24.000 | 24.000 | |||||
| 2017-03-22 | 2017-03-20 | 4 | TYLER JOSEPH E | AGLE | Employee Stock Option (right to buy) | D | 8,03 | 39.000 | 39.000 | |||||
| 2017-03-22 | 2017-03-20 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 8,03 | 90.000 | 90.000 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Hebel Henry | AGLE | Employee Stock Option (right to buy) | D | 8,03 | 38.200 | 38.200 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Lowe David George | AGLE | Employee Stock Option (right to buy) | D | 8,03 | 160.000 | 160.000 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Rowlinson Scott W | AGLE | Employee Stock Option (right to buy) | D | 8,03 | 60.000 | 60.000 | |||||
| 2017-02-21 | 2017-02-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | AGLE | Common Stock | I | 5,3600 | 7.000 | 38 | 1.469.524 | ||||
| 2017-02-21 | 2017-02-17 | 4 | ORBIMED ADVISORS LLC See Footnotes | AGLE | Common Stock | I | 5,1900 | 71.800 | 373 | 1.462.524 | ||||
| 2017-02-21 | 2017-02-16 | 4 | ORBIMED ADVISORS LLC See Footnotes | AGLE | Common Stock | I | 5,0400 | 30.500 | 154 | 1.390.724 | ||||
| 2017-02-16 | 2017-02-15 | 4 | Bruhn Suzanne Louise | AGLE | Director Stock Option (right to buy) | D | 5,04 | 82.000 | 82.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Cox Russell J. | AGLE | Director Stock Option (right to buy) | D | 7,28 | 10.000 | 10.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Lowe David George | AGLE | Employee Stock Option (right to buy) | D | 7,28 | 160.000 | 160.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Mahatme Sandesh | AGLE | Director Stock Option (right to buy) | D | 7,28 | 10.000 | 10.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | TYLER JOSEPH E | AGLE | Employee Stock Option (right to buy) | D | 7,28 | 33.000 | 33.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | York Charles N II | AGLE | Employee Stock Option (right to buy) | D | 7,28 | 55.000 | 55.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Rowlinson Scott W | AGLE | Employee Stock Option (right to buy) | D | 7,28 | 47.000 | 47.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Shanafelt Armen | AGLE | Director Stock Option (right to buy) | D | 7,28 | 24.000 | 24.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Hebel Henry | AGLE | Employee Stock Option (right to buy) | D | 7,28 | 43.000 | 43.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | Rojas-Caro Sandra | AGLE | Employee Stock Option | D | 7,28 | 200.000 | 200.000 | |||||
| 2016-05-19 | 2016-05-17 | 4 | GEORGIOU GEORGE | AGLE | Director Stock Option (right to buy) | D | 7,28 | 24.000 | 24.000 | |||||
| 2016-04-19 | 3 | ISALY SAMUEL D | AGLE | Common Stock | I | 2.720.448 | ||||||||
| 2016-04-19 | 3 | ISALY SAMUEL D | AGLE | Common Stock | I | 2.720.448 | ||||||||
| 2016-04-19 | 3 | ISALY SAMUEL D | AGLE | Common Stock | I | 2.720.448 | ||||||||
| 2016-04-19 | 3 | ISALY SAMUEL D | AGLE | Common Stock | I | 2.720.448 | ||||||||
| 2016-04-14 | 3/A | Shanafelt Armen by fund | AGLE | Common Stock | I | 57.619 | ||||||||
| 2016-04-14 | 2016-04-12 | 4/A | LILLY ELI & CO by fund | AGLE | Common Stock | I | 2.010.924 | 2.068.543 | ||||||
| 2016-04-14 | 2016-04-12 | 4 | LILLY ELI & CO by fund | AGLE | Series B Preferred Stock | I | 0,00 | -1.120.448 | 0 | |||||
| 2016-04-14 | 2016-04-12 | 4 | LILLY ELI & CO by fund | AGLE | Series A Preferred Stock | I | 0,00 | -890.476 | 0 | |||||
| 2016-04-14 | 2016-04-12 | 4 | LILLY ELI & CO by fund | AGLE | Common Stock | I | 10,0000 | 500.000 | 5.000 | 2.568.543 | ||||
| 2016-04-14 | 2016-04-12 | 4 | LILLY ELI & CO by fund | AGLE | Common Stock | I | 2.010.924 | 2.068.543 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | Cox Russell J. | AGLE | Common Stock | D | 10,0000 | 7.000 | 70 | 7.000 | ||||
| 2016-04-12 | 2016-04-12 | 4 | Lowe David George By trust | AGLE | Series B Preferred Stock | I | 0,00 | -2.801 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | Lowe David George By trust | AGLE | Series A Preferred Stock | I | 0,00 | -2.857 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | Lowe David George By trust | AGLE | Common Stock | I | 5.658 | 5.658 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | Novartis Bioventures Ltd | AGLE | Series B Preferred Stock | D | 0,00 | -1.120.448 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | Novartis Bioventures Ltd | AGLE | Series A Preferred Stock | D | 0,00 | -890.476 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 10,0000 | 300.000 | 3.000 | 2.310.924 | ||||
| 2016-04-12 | 2016-04-12 | 4 | Novartis Bioventures Ltd | AGLE | Common Stock | D | 2.010.924 | 2.010.924 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | Quinn Anthony | AGLE | Common Stock | D | 10,0000 | 10.000 | 100 | 10.000 | ||||
| 2016-04-12 | 2016-04-12 | 4 | TYLER JOSEPH E | AGLE | Series B Preferred Stock | D | 0,00 | -8.403 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | TYLER JOSEPH E | AGLE | Series A Preferred Stock | D | 0,00 | -22.857 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | TYLER JOSEPH E | AGLE | Common Stock | D | 31.260 | 42.428 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | York Charles N II By IRA | AGLE | Series B Preferred Stock | I | 0,00 | -2.037 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | York Charles N II By IRA | AGLE | Series A Preferred Stock | I | 0,00 | -9.523 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | York Charles N II | AGLE | Series B Preferred Stock | D | 0,00 | -1.324 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | York Charles N II By IRA | AGLE | Common Stock | I | 11.560 | 11.560 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | York Charles N II | AGLE | Common Stock | D | 1.324 | 8.828 | ||||||
| 2016-04-12 | 2016-04-12 | 4 | Rowlinson Scott W By trust | AGLE | Series B Preferred Stock | I | 0,00 | -11.204 | 0 | |||||
| 2016-04-12 | 2016-04-12 | 4 | Rowlinson Scott W By trust | AGLE | Common Stock | I | 11.204 | 11.204 | ||||||
| 2016-04-06 | 3 | Shanafelt Armen By fund | AGLE | Common Stock | I | 115.238 | ||||||||
| 2016-04-06 | 3 | Shanafelt Armen By fund | AGLE | Common Stock | I | 115.238 | ||||||||
| 2016-04-06 | 3 | Rowlinson Scott W | AGLE | Common Stock | D | 33.498 | ||||||||
| 2016-04-06 | 3 | Rowlinson Scott W | AGLE | Common Stock | D | 33.498 | ||||||||
| 2016-04-06 | 3 | TYLER JOSEPH E | AGLE | Common Stock | D | 22.336 | ||||||||
| 2016-04-06 | 3 | TYLER JOSEPH E | AGLE | Common Stock | D | 22.336 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE | AGLE | Common Stock | D | 547.532 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE By trust | AGLE | Common Stock | I | 514.480 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE Held by GMA Technologies L.L.C. | AGLE | Common Stock | I | 574.004 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE By trust | AGLE | Common Stock | I | 514.480 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE | AGLE | Common Stock | D | 547.532 | ||||||||
| 2016-04-06 | 3 | GEORGIOU GEORGE Held by GMA Technologies L.L.C. | AGLE | Common Stock | I | 574.004 | ||||||||
| 2016-04-06 | 3 | Lowe David George | AGLE | Common Stock | D | 412.764 | ||||||||
| 2016-04-06 | 3 | Lowe David George | AGLE | Common Stock | D | 412.764 | ||||||||
| 2016-04-06 | 3 | York Charles N II | AGLE | Common Stock | D | 15.008 | ||||||||
| 2016-04-06 | 3 | York Charles N II | AGLE | Common Stock | D | 15.008 | ||||||||
| 2016-04-06 | 3 | Torres S. Edward | AGLE | Common Stock | D | 115.238 | ||||||||
| 2016-04-06 | 3 | Torres S. Edward | AGLE | Common Stock | D | 115.238 | ||||||||
| 2016-04-06 | 3 | Torres S. Edward | AGLE | Common Stock | D | 115.238 | ||||||||
| 2016-04-06 | 3 | Torres S. Edward | AGLE | Common Stock | D | 115.238 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
